GET THE APP

Ethical issues in pharmaceutical electronic detailing (e-detailin | 29068
Journal of Pharmaceutical Care & Health Systems

Journal of Pharmaceutical Care & Health Systems
Open Access

ISSN: 2376-0419

+44 1300 500008

Ethical issues in pharmaceutical electronic detailing (e-detailing)


European Pharma Congress

August 25-27, 2015 Valencia, Spain

Fadi M Alkhateeb

Texas A&M University Health Science Center College of Pharmacy, USA

Posters-Accepted Abstracts: J Pharma Care Health Sys

Abstract :

Electronic detailing (e-detailing) has been introduced in the last few years by the pharmaceutical industry as a new communication channel to promote pharmaceutical products to physicians. E-detailing means using digital technology: internet, video conferencing and interactive voice response. There are two types of e-detailing: interactive (virtual) and video. Currently, little is known about what factors influence physicians��? adoption of e-detailing. Studies show that e- detailing has become more influential on physicians��? prescribing behaviors than pharmaceutical sales representatives visits. Many academic and hospital-based practice institutions follow a policy to restrict using e-detailing in their institutions because the information conveyed is selective and may be biased for their product. Other studies have shown that using e-detailing influence requests to add new medications to hospital formularies, increasing the cost of prescribing. Because of the influence of e-detailing on physician prescribing behavior and the varying frequency of adopting e-detailing among physicians, it is important to investigate those factors that influence physicians��? decisions to adopt e-detailing. Moreover, we need to investigate the emerging ethical dilemmas and policy issues in using e-detailing among physicians. The lack of research about these factors results in a lack of clear guidance for policymakers to effectively manage e-detailing.

Biography :

Email: alkhateeb@pharmacy.tamhsc.edu

Top